Olon is a leading international Generic Active Pharmaceutical Ingredients (API) supplier. We manufacture API via chemical as well as biological synthesis, relying on extended internal technical expertise while meeting the highest standards of quality and reliability, being competitive and cost-effective.
With a portfolio of 300 Generic APIs, we offer one of the most extensive track records in the industry, and we manage more than 450 Drug Master Files WW. Our portfolio embraces all the major therapeutic areas including oncology, CNS, infectious disease, immunology, dermatology, cardiovascular and many others.
Being an early adopter of the most advanced technology and processes, and handling the broadest range of analytical capabilities, we represent a partner enhancing competitiveness and time to market.
We have diversified and backed investments across several lines and multiple facilities to be able to manage various high-containment molecules at different scales and guarantee flexibility on a significant scale.
Our comprehensive analytical testing services are carried out fully in house; this translates to significant time and cost savings for our clients. Our clients can also rely on one of the widest ranges of leading-edge technologies, chemistry, and biotechnology expertise.
We represent an agile and versatile API provider able to meet the needs of the most demanding clients, both of generic and innovative pharma industry.
We customize our API from a chemical and physical viewpoint to match the specific and stringent project requirements of our customers; furthermore, our strong quality and regulatory expertise allow us to manage at best the approvals from the most demanding local authorities.